Skip to main content

Table 2 Distribution and frequencies of IL-17A and IL-17F genotypes in metastatic colorectal cancer patients (n = 122)

From: A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

Polymorphisms

n

(%)

IL-17A (rs2275913)

 AA

14

11,47

 AG

63

51,65

 GG

45

36,88

IL-17F (rs763780)

 AA

116

95,08

 AG

6

4,92

 GG

0

0

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us